Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research program which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.
Latest funding size
Time since last funding
|Draper Fisher Jurvetson (DFJ), GE Ventures, Bryan Johnson, Illumina, Celgene, StartUp Health, Amino Capital, Daniel Curran, Tan Thay, Synthetic Genomics|